The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects
- PMID: 2050170
- DOI: 10.1007/BF00265843
The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects
Abstract
The effects of a 10 day administration of clomipramine (25-50 mg t.i.d.), alprazolam (0.25-0.75 mg t.i.d.) and placebo were assessed in normal volunteers in a double-blind cross-over study. A battery of physiological, psychomotor and cognitive tests was administered both before and 3 h after drug on days 1, 5 and 10. The effects of alprazolam on EEG and evoked potentials were characteristic of benzodiazepines; clomipramine had little effect. In contrast, reaction speed was markedly slowed by clomipramine but little affected by alprazolam. Neither drug produced any accumulation of effect on a verbal recall task but neither did tolerance develop to the acute impairments produced by active treatments. Alprazolam produced an increase in levels of forgetting, especially on day 5. Subjective ratings for mood and bodily symptoms were adversely affected by clomipramine but little altered by alprazolam. It is suggested that some of the differences between drug treatments may be due to differences in the speed of onset of tolerance.
Similar articles
-
Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.Am J Psychiatry. 1991 Jan;148(1):73-7. doi: 10.1176/ajp.148.1.73. Am J Psychiatry. 1991. PMID: 1984710 Clinical Trial.
-
Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.Eur J Clin Pharmacol. 1990;39(1):21-8. doi: 10.1007/BF02657051. Eur J Clin Pharmacol. 1990. PMID: 2276384 Clinical Trial.
-
Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.Psychopharmacology (Berl). 2007 May;191(4):951-9. doi: 10.1007/s00213-006-0669-8. Epub 2007 Jan 12. Psychopharmacology (Berl). 2007. PMID: 17219217 Clinical Trial.
-
Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.Neuropsychobiology. 2007;55(3-4):203-12. doi: 10.1159/000108379. Epub 2007 Sep 17. Neuropsychobiology. 2007. PMID: 17878744 Clinical Trial.
-
A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.Psychopharmacology (Berl). 2005 Dec;183(2):133-43. doi: 10.1007/s00213-005-0172-7. Epub 2005 Nov 9. Psychopharmacology (Berl). 2005. PMID: 16205916 Clinical Trial.
Cited by
-
Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adults.Exp Clin Psychopharmacol. 2025 Apr;33(2):178-188. doi: 10.1037/pha0000746. Epub 2024 Nov 14. Exp Clin Psychopharmacol. 2025. PMID: 39541522 Clinical Trial.
-
Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study.J Psychopharmacol. 2023 Dec;37(12):1227-1237. doi: 10.1177/02698811231200878. Epub 2023 Sep 19. J Psychopharmacol. 2023. PMID: 37724443 Free PMC article. Clinical Trial.
-
Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.Psychopharmacology (Berl). 1995 Mar;118(1):1-9. doi: 10.1007/BF02245243. Psychopharmacology (Berl). 1995. PMID: 7597114 Clinical Trial.
-
The interactions of ethanol with single and repeated doses of suriclone and diazepam on physiological and psychomotor functions in normal subjects.Eur J Clin Pharmacol. 1992;42(5):499-505. doi: 10.1007/BF00314858. Eur J Clin Pharmacol. 1992. PMID: 1351467
-
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?Adv Pharmacol Sci. 2012;2012:416864. doi: 10.1155/2012/416864. Epub 2012 Mar 29. Adv Pharmacol Sci. 2012. PMID: 22536226 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources